Statistics from Altmetric.com
Proton pump inhibitors (PPI) are a safe and effective treatment of acid-related disorders such as gastroesophageal reflux disease and Barrett's oesophagus. However, they may be associated with an increased risk of Clostridium difficile infection (CDI).
Kwok and colleagues conducted a systematic review and meta-analysis of observational studies evaluating the association between PPI and the risk of primary or recurrent CDI. Relevant articles were identified through a comprehensive literature search including MEDLINE, EMBASE (from database inception to December 2011) and reference lists of articles retrieved from these bibliographical databases. Studies were eligible for inclusion in the meta-analysis if they were either case–control or cohort design, and either reported OR, risk ratios (RR) or provided sufficient data to allow manual calculation of these …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.